Table 1 Population descriptors (n = 298)
From: The impact of vascular anastomosis time on early kidney transplant outcomes
| Descriptor | Value |
|---|---|
| Age, years, mean ± SD | 51 ± 13 |
| Gender, male, number (%) | 181 (60.7%) |
| Regraft, number (%) | 29 (9.0%) |
| Diabetes mellitus, number (%) | 69 (23%) |
| End-stage renal disease | |
| Polycystic kidney disease, number (%) | 55 (19%) |
| Glomerulonephritis, number (%) | 85 (29%) |
| Diabetes mellitus, number (%) | 50 (17%) |
| Recipient weight, kg, mean ± SD | 78 ± 17 |
| Recipient body mass index, kg/m2, mean ± SD | 28 ± 5 |
| Blood transfusion, never, number (%) | 205 (69%) |
| Human leukocyte antigen mismatch, mean ± SD | 4.1 ± 1.4 |
| Dialysis duration, days, median (IQR) | 819 (419, 1462) |
| Calculated panel reactive antibody, %, median (IQR) | 0 (0, 8) |
| Cold ischemic time, hours, median (IQR) | 12 (8, 16) |
| Anastamosis time, minutes, median (IQR) | 30 (24, 45) |
| Donation after circulatory death, number (%) | 16 (5.4%) |
| Donor cause of death | |
| Anoxia, number (%) | 24 (8%) |
| Cerebrovascular event, number (%) | 189 (62%) |
| Donor age years, mean ± SD | 47 ± 17 |
| Donor male, number (%) | 135 (45%) |
| Donor weight kg, mean ± SD | 76 ± 19 |
| Donor body mass index kg/m2, mean ± SD | 27 ± 6 |
| Donor creatinine μmol/L, mean ± SD | 67 ± 31 |
| Delayed graft function, number (%) | 56 (18.8%) |
| Days in hospital, days, median (IQR) | 9 (7, 14) |
| Creatinine day 7, μmol/L, median (IQR) | 168 (125, 314) |